S. Marien

Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine.

K. Nackaerts, Y. Humblet, J. Vansteenkiste, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice.

R. Stupp, J. Pujol, J. Douillard, 2000, Lung cancer.

Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).

D. Schallier, M. Potvin, P. Glorieux, 2001, Anticancer research.

Combination chemotherapy with vindesine-ifosfamide-cisplatin (VIP) in locally advanced unresectable stage III and in stage IV non-small cell lung cancer: a phase II trial.

J. Vansteenkiste, H. Ulrichts, R. Deman, 1995, Lung cancer.